Citadel Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7,800
Closed -$223K – 15051
2026
Q2
$223K Sell
7,800
-1,700
-18% -$54K ﹤0.01% 11812
2026
Q1
$299K Buy
+9,500
New +$299K ﹤0.01% 10479
2025
Q2
– Sell
-5,900
Closed -$135K – 14710
2025
Q1
$135K Sell
5,900
-21,300
-78% -$514K ﹤0.01% 11032
2024
Q4
$689K Sell
27,200
-7,600
-22% -$193K ﹤0.01% 7870
2024
Q3
$868K Sell
34,800
-47,700
-58% -$1.41M ﹤0.01% 7149
2024
Q2
$2.45M Buy
82,500
+45,900
+125% +$1.27M ﹤0.01% 4943
2024
Q1
$1.1M Buy
36,600
+36,300
+12,100% +$1.01M ﹤0.01% 6721
2023
Q4
$8.58K Sell
300
-1,200
-80% -$35.2K ﹤0.01% 13212
2023
Q3
$55.6K Sell
1,500
-5,800
-79% -$222K ﹤0.01% 11633
2023
Q2
$285K Buy
7,300
+6,104
+510% +$239K ﹤0.01% 9164
2023
Q1
$43.7K Sell
1,196
-100
-8% -$3.16K ﹤0.01% 12337
2022
Q4
$39.9K Buy
+1,296
New +$40.2K ﹤0.01% 12419

Other funds holding RTO

Citadel Advisors's RTO Position: Q3 2026 in Review

Citadel Advisors increased its Rentokil (RTO) stake by 8,618% in Q3 2026, buying an estimated $57.9M and bringing the position to 2,335,143 shares worth $46.1M. The position accounts for 0.01% of the portfolio, ranked #1628.

Citadel Advisors first reported a position in RTO in Q4 2022 and has held it in 13 quarters since. 258 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Citadel Advisors held 2,335,143 shares of Rentokil worth $46.1M as of Q3 2026.
  • Citadel Advisors bought 2,308,359 Rentokil shares in Q3 2026, an estimated $57.9M.
  • Rentokil made up 0.01% of Citadel Advisors's portfolio in Q3 2026, its #1628 holding.
  • Citadel Advisors first reported a position in Rentokil in Q4 2022 and has held it in 13 quarters since.
  • 258 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.